Albuminuria changes and subsequent risk of end-stage renal disease and mortality
暂无分享,去创建一个
J. Coresh | A. Levey | J. Carrero | R. Gansevoort | K. Matsushita | M. Grams | M. Evans | Y. Sang | B. Lindholm | P. Bárány | S. Ballew | Johan | Shoshana H. Ballew | Alessandro Gasparini | Qureshi | Ärnlöv | R. Abdul | Carl-Gustav Elinder | J. Coresh | M. Evans
[1] Marie Evans,et al. The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness , 2015, Clinical kidney journal.
[2] J. Hoekman,et al. Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis. , 2015, Journal of the American Society of Nephrology : JASN.
[3] M. Woodward,et al. Kidney measures beyond traditional risk factors for cardiovascular prediction: A collaborative meta-analysis , 2015, The lancet. Diabetes & endocrinology.
[4] M. Woodward,et al. Assessing the Validity of Surrogate Outcomes for ESRD: A Meta-Analysis. , 2015, Journal of the American Society of Nephrology : JASN.
[5] J. Lewis,et al. Albuminuria is Not an Appropriate Therapeutic Target in Patients with CKD: The Con View. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[6] R. Gansevoort,et al. Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[7] A. Cheung,et al. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] K. Duffin,et al. A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] Tom Greene,et al. Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] J. Coresh,et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. , 2014, JAMA.
[11] Harold I Feldman,et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] Paul Shekelle,et al. Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease: A Clinical Practice Guideline From the American College of Physicians , 2013, Annals of Internal Medicine.
[13] Kai-Uwe Eckardt,et al. Evolving importance of kidney disease: from subspecialty to global health burden , 2013, The Lancet.
[14] A. Levin,et al. Practice Guideline , 2020, Encyclopedia of Behavioral Medicine.
[15] B. Kasiske,et al. KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease Foreword , 2013 .
[16] Shah Ebrahim,et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.
[17] A. Thompson. Proteinuria as a surrogate end point—more data are needed , 2012, Nature Reviews Nephrology.
[18] G. Remuzzi,et al. Proteinuria should be used as a surrogate in CKD , 2012, Nature Reviews Nephrology.
[19] S. Yusuf,et al. Changes in albuminuria predict mortality and morbidity in patients with vascular disease. , 2011, Journal of the American Society of Nephrology : JASN.
[20] Mark Woodward,et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. , 2011, Kidney international.
[21] Laura E. Clark,et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. , 2011, Kidney international.
[22] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[23] Stian Lydersen,et al. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. , 2009, Journal of the American Society of Nephrology : JASN.
[24] D. de Zeeuw,et al. First morning voids are more reliable than spot urine samples to assess microalbuminuria. , 2009, Journal of the American Society of Nephrology : JASN.
[25] Anders Sundström,et al. The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months , 2007, Pharmacoepidemiology and drug safety.
[26] D. Levy,et al. Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals: The Framingham Heart Study , 2005, Circulation.
[27] K Doqi,et al. clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .
[28] H. Keen,et al. MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS , 1982, The Lancet.
[29] H. Parving,et al. Reduced Albuminuria During Early and Aggressive Antihypertensive Treatment of Insulin-dependent Diabetic Patients with Diabetic Nephropathy , 1981, Diabetes Care.